SMTL ID : 8ubr.1

Complex of the phosphorylated human cystic fibrosis transmembrane conductance regulator (CFTR) with CFTRinh-172 and ATP/Mg

Coordinates

PDB Format

Method

ELECTRON MICROSCOPY

Oligo State

monomer

Ligands

2 x MG: MAGNESIUM ION(Non-covalent)

MG.1: 3 residues within 4Å: Chain A: T.465, Q.493 Ligands: ATP.2 3 PLIP interactions: 1 interactions with chain A, 2 Ligand-Water interactions Metal complexes: A:T.465, H2O.1, H2O.1 MG.9: 3 residues within 4Å: Chain A: S.1251, Q.1291 Ligands: ATP.3 3 PLIP interactions: 1 interactions with chain A, 2 Ligand-Water interactions Metal complexes: A:S.1251, H2O.1, H2O.1

2 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)

ATP.2: 18 residues within 4Å: Chain A: W.401, V.440, S.459, T.460, G.461, A.462, G.463, K.464, T.465, S.466, Q.493, Q.1330, C.1344, V.1345, S.1347, H.1348, G.1349 Ligands: MG.1 19 PLIP interactions: 19 interactions with chain A Hydrogen bonds: A:G.461, A:A.462, A:G.463, A:K.464, A:T.465, A:S.466, A:Q.493, A:Q.1330, A:C.1344, A:S.1347, A:H.1348, A:G.1349 Water bridges: A:T.465, A:T.465, A:Q.493 Salt bridges: A:K.464, A:K.464 pi-Stacking: A:W.401, A:W.401 ATP.3: 18 residues within 4Å: Chain A: T.547, S.549, G.550, G.551, Q.552, Y.1219, I.1226, R.1245, T.1246, G.1247, S.1248, G.1249, K.1250, S.1251, T.1252, Q.1291, H.1402 Ligands: MG.9 24 PLIP interactions: 24 interactions with chain A Hydrogen bonds: A:I.546, A:T.547, A:S.549, A:G.550, A:G.551, A:Q.552, A:Q.552, A:G.1247, A:G.1247, A:S.1248, A:G.1249, A:K.1250, A:S.1251, A:S.1251, A:S.1251, A:T.1252, A:T.1252, A:Q.1291 Water bridges: A:S.1251 Salt bridges: A:K.1250, A:K.1250, A:H.1402 pi-Stacking: A:Y.1219, A:Y.1219

2 x LBN: 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine(Non-functional Binders)(Non-covalent)

LBN.4: 1 residues within 4Å: Ligands: CLR.6 No protein-ligand interaction detected (PLIP) LBN.5: 4 residues within 4Å: Chain A: Y.362, L.365, G.366, N.369 4 PLIP interactions: 4 interactions with chain A Hydrophobic interactions: A:Y.362, A:Y.362, A:L.365, A:L.365

2 x CLR: CHOLESTEROL(Non-covalent)

CLR.6: 6 residues within 4Å: Chain A: Y.89, L.206, L.210, W.216 Ligands: LBN.4, CLR.7 3 PLIP interactions: 3 interactions with chain A Hydrophobic interactions: A:L.206, A:L.210, A:L.210 CLR.7: 5 residues within 4Å: Chain A: Y.89, L.90, V.93, E.217 Ligands: CLR.6 1 PLIP interactions: 1 interactions with chain A Hydrophobic interactions: A:V.93

1 x WG5: 4-[(Z)-{(3M)-4-oxo-2-sulfanylidene-3-[3-(trifluoromethyl)phenyl]-1,3-thiazolidin-5-ylidene}methyl]benzoic acid(Non-covalent)

WG5.8: 11 residues within 4Å: Chain A: K.95, M.348, A.923, D.924, I.1000, A.1004, N.1138, I.1139, S.1141, T.1142, W.1145 2 PLIP interactions: 2 interactions with chain A Hydrophobic interactions: A:W.1145 Salt bridges: A:K.95

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Young, P.G. et al., Structural basis for CFTR inhibition by CFTR inh -172. Proc.Natl.Acad.Sci.USA (2024)

Release Date

2024-02-21

Peptides

Cystic fibrosis transmembrane conductance regulator: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Membrane

We predict this structure to be a membrane protein.
Show / Hide

Cystic fibrosis transmembrane conductance regulator

Related Entries With Identical Sequence